Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
Jingen LiJianqing JuZhuo ChenJing LiuFang LuRui GaoHao XuPublished in: Trials (2018)
Chinese Clinical Trial Registry, ChiCTR-IIR-17010688 . Registered on 20 February 2017.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- clinical trial
- study protocol
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- phase ii
- open label
- randomized controlled trial
- coronary artery bypass
- double blind
- atrial fibrillation
- cardiovascular disease
- type diabetes
- placebo controlled